Free Trial

Geron (GERN) News Today

Geron logo
$1.38 -0.05 (-3.50%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$1.41 +0.03 (+2.46%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Geron Co. stock logo
Geron Co. (NASDAQ:GERN) Shares Sold by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD lowered its position in Geron Co. (NASDAQ:GERN - Free Report) by 44.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,941,035 shares of the biopharmaceutical company's stock after selling
Geron Co. stock logo
Geron Co. (NASDAQ:GERN) Shares Sold by Ally Bridge Group NY LLC
Ally Bridge Group NY LLC trimmed its holdings in Geron Co. (NASDAQ:GERN - Free Report) by 19.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,074,824 shares of the biopharmaceutical company's stock after selling 256,229
Geron Co. stock logo
Boxer Capital Management LLC Buys New Stake in Geron Co. (NASDAQ:GERN)
Boxer Capital Management LLC purchased a new position in shares of Geron Co. (NASDAQ:GERN - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,000,000 shares of the biopharma
Analysts Set Geron Co. (NASDAQ:GERN) PT at $5.38
Geron Co. stock logo
RA Capital Management L.P. Sells 2,276,219 Shares of Geron Co. (NASDAQ:GERN)
RA Capital Management L.P. decreased its stake in shares of Geron Co. (NASDAQ:GERN - Free Report) by 7.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 30,009,536 shares of the biopharmaceutical company's stock after selling 2,276,219 shares
Geron Co. stock logo
Geron Co. (NASDAQ:GERN) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Geron Co. (NASDAQ:GERN - Get Free Report) have been given a consensus rating of "Moderate Buy" by the nine brokerages that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, six have given a buy rating and one has give
Geron Co. stock logo
Geron (GERN) to Release Earnings on Wednesday
Geron (NASDAQ:GERN) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-geron-co-stock/)
Geron Co. stock logo
Aquatic Capital Management LLC Invests $1.48 Million in Geron Co. (NASDAQ:GERN)
Aquatic Capital Management LLC acquired a new stake in Geron Co. (NASDAQ:GERN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 418,541 shares of the biopharmaceutical company's stock
Geron Co. stock logo
Geron Co. (NASDAQ:GERN) Stake Cut by Darwin Global Management Ltd.
Darwin Global Management Ltd. lessened its holdings in shares of Geron Co. (NASDAQ:GERN - Free Report) by 56.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,569,835 shares of the biopharmaceutical company's
Geron Co. stock logo
Tri Locum Partners LP Invests $8.75 Million in Geron Co. (NASDAQ:GERN)
Tri Locum Partners LP bought a new stake in Geron Co. (NASDAQ:GERN - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 2,472,836 shares of the biopharmaceutical company's stock, valued at approximately $8,754,000. Geron
Geron Co. stock logo
Barclays PLC Purchases 228,837 Shares of Geron Co. (NASDAQ:GERN)
Barclays PLC grew its holdings in Geron Co. (NASDAQ:GERN - Free Report) by 17.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,528,749 shares of the biopharmaceutical company's stock after purchasing an additio
Geron Co. stock logo
Invesco Ltd. Sells 385,925 Shares of Geron Co. (NASDAQ:GERN)
Invesco Ltd. reduced its position in shares of Geron Co. (NASDAQ:GERN - Free Report) by 15.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,077,602 shares of the biopharmaceutical company's stock after sel
Geron Co. stock logo
Geron Co. (NASDAQ:GERN) Shares Sold by Adage Capital Partners GP L.L.C.
Adage Capital Partners GP L.L.C. trimmed its holdings in Geron Co. (NASDAQ:GERN - Free Report) by 24.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,800,000 shares of the biopharmace
Geron Co. stock logo
Guggenheim Capital LLC Takes $760,000 Position in Geron Co. (NASDAQ:GERN)
Guggenheim Capital LLC purchased a new position in Geron Co. (NASDAQ:GERN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 214,828 shares of the biopharmaceutical company's stock,
Geron Co. stock logo
What is Wedbush's Forecast for Geron FY2029 Earnings?
Geron Co. (NASDAQ:GERN - Free Report) - Wedbush issued their FY2029 earnings estimates for shares of Geron in a research note issued to investors on Monday, April 21st. Wedbush analyst R. Driscoll forecasts that the biopharmaceutical company will post earnings of $0.96 per share for the year. The
Geron Co. stock logo
Leerink Partnrs Has Bearish Outlook for Geron Q2 Earnings
Geron Co. (NASDAQ:GERN - Free Report) - Leerink Partnrs decreased their Q2 2025 earnings per share estimates for Geron in a report released on Monday, April 21st. Leerink Partnrs analyst F. Khurshid now anticipates that the biopharmaceutical company will post earnings per share of ($0.04) for the
Geron Co. stock logo
Marshall Wace LLP Increases Stock Position in Geron Co. (NASDAQ:GERN)
Marshall Wace LLP increased its position in shares of Geron Co. (NASDAQ:GERN - Free Report) by 73.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,202,995 shares of the biopharmaceutical company's stock after purchasing an additio
Leerink Partnrs Predicts Geron's Q2 Earnings (NASDAQ:GERN)
Geron Co. stock logo
Geron Co. (NASDAQ:GERN) Shares Sold by Silverarc Capital Management LLC
Silverarc Capital Management LLC lessened its position in shares of Geron Co. (NASDAQ:GERN - Free Report) by 48.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 920,022 shares of the biopharmaceutical c
Geron Co. stock logo
Diadema Partners LP Makes New $708,000 Investment in Geron Co. (NASDAQ:GERN)
Diadema Partners LP purchased a new position in Geron Co. (NASDAQ:GERN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 200,000 shares of the biopharmaceutical company's
Geron Co. stock logo
1,211,700 Shares in Geron Co. (NASDAQ:GERN) Acquired by Natixis
Natixis acquired a new stake in Geron Co. (NASDAQ:GERN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,211,700 shares of the biopharmaceutical company's stock, valued at approximately $4
Get Geron News Delivered to You Automatically

Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter.

GERN Media Mentions By Week

GERN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GERN
News Sentiment

0.24

0.73

Average
Medical
News Sentiment

GERN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GERN Articles
This Week

24

11

GERN Articles
Average Week

Get Geron News Delivered to You Automatically

Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GERN) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners